Abstract
Glecaprevir (GLE) and pibrentasvir (PIB) are direct-acting antivirals coformulated as a combination tablet for once-daily treatment of chronic hepatitis C virus infection. The objective of this study was to evaluate the effect of different methods of tablet manipulations-cutting in half, grinding into powder, or crushing-on the bioavailability of GLE and PIB relative to whole film-coated bilayer tablets. This was a phase 1, single-dose, open-label, randomized, 5-period, nonfasting crossover study in 25 healthy adult male and female subjects. Intensive pharmacokinetic measurements were carried out up to 48 h after dosing on day 1 of each period. Safety and tolerability was assessed throughout the study. Compared with the reference whole tablets, cutting into half had minimal impact on GLE and PIB exposures (≤15% difference), whereas grinding or crushing the tablets resulted in lower exposures (27% to 61%) for GLE and higher exposures (21% to 83%) for PIB. These results provide guidance on appropriate administration of GLE/PIB in patients who have difficulty swallowing whole tablets.
Citations
May 28, 2019·Clinical Journal of Gastroenterology·Yasuo TanakaKazuhiko Koike
Oct 15, 2019·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Peng-Sheng TingPo-Hung Chen
Oct 22, 2019·Transplantation·James R BurtonElizabeth A Pomfret
Jan 14, 2020·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Amanda MogulAndrew R Zullo
Dec 7, 2019·Therapeutic Drug Monitoring·Sébastien LalanneFlorian Lemaitre
Jun 17, 2020·The Journal of Antimicrobial Chemotherapy·Daniëlle W M PijnenburgDavid M Burger
Jul 8, 2020·Clinical Transplantation·Tyler C LewisNader Moazami
Mar 21, 2020·Therapeutic Drug Monitoring·Sébastien LalanneFlorian Lemaitre
Jun 25, 2019·The Journal of Clinical Investigation·Christine M Durand, Michael A Chattergoon
Dec 11, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Autumn D ZuckermanTara Kelley
Jan 1, 2021·Pharmaceutics·Nélio Drumond, Sven Stegemann
Feb 18, 2021·Current Opinion in Organ Transplantation·Christopher J DanfordDiane Alonso
May 5, 2020·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Saima AslamUNKNOWN working group members
Oct 25, 2020·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Humberto BohorquezGeorge E Loss
May 3, 2021·Pharmacotherapy·Rajeev B ShahAmanda J Noska